SEC Filings

Form 10-Q
NOVAN, INC. filed this Form 10-Q on 11/05/2018
Document Outline
Entire Document (3903.7 KB)
Subdocument 1 - 10-Q - 10-Q
Page 1 - UNITED STATES
Page 2 - N/A
Page 3 - PART I FINANCIAL INFORMATION
Page 4 - NOVAN, INC.
Page 5 - NOVAN, INC.
Page 6 - NOVAN, INC.
Page 7 - NOVAN, INC.
Page 8 - NOVAN, INC.
Page 9 - NOVAN, INC.
Page 10 - NOVAN, INC.
Page 11 - NOVAN, INC.
Page 12 - NOVAN, INC.
Page 13 - NOVAN, INC.
Page 14 - NOVAN, INC.
Page 15 - NOVAN, INC.
Page 16 - NOVAN, INC.
Page 17 - NOVAN, INC.
Page 18 - NOVAN, INC.
Page 19 - NOVAN, INC.
Page 20 - NOVAN, INC.
Page 21 - NOVAN, INC.
Page 22 - NOVAN, INC.
Page 23 - NOVAN, INC.
Page 24 - NOVAN, INC.
Page 25 - NOVAN, INC.
Page 26 - NOVAN, INC.
Page 27 - NOVAN, INC.
Page 28 - NOVAN, INC.
Page 29 - NOVAN, INC.
Page 30 - NOVAN, INC.
Page 31 - NOVAN, INC.
Page 32 - Item 2: Management s Discussion and Analysis of Financial Condition and Results of Operations
Page 33 - We currently manufacture clinical trial materials internally and we intend to utilize third parties,
Page 34 - Overview
Page 35 - N/A
Page 36 - Corporate Updates
Page 37 - Drug Manufacturing Agreement with Orion Pharmaceuticals
Page 38 - Financial Overview
Page 39 - Components of our Results of Operations
Page 40 - N/A
Page 41 - General and Administrative Expenses
Page 42 - Results of Operations
Page 43 - General and administrative expenses
Page 44 - Revenue
Page 45 - Liquidity and Capital Resources
Page 46 - Facility Lease Financing
Page 47 - Net Cash Used in Investing Activities
Page 48 - N/A
Page 49 - Contractual Obligations and Contingent Liabilities
Page 50 - Revenue Recognition
Page 51 - Recent Accounting Pronouncements
Page 52 - Item 4. Controls and Procedures
Page 53 - PART II OTHER INFORMATION
Page 54 - Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Page 55 - N/A
Page 56 - SIGNATURES
Subdocument 2 - EX-10.1 - EXHIBIT 10.1
Page 1 - Exhibit 10.1
Page 2 - 1.47 Licensed Product
Page 3 - 14.3 Notification
Page 4 - 15.1Royalty
Page 5 - [Signature page follows]
Page 6 - [***] Certain information in this document has been omitted and filed separately with the Securities
Page 7 - Annex 2: Patent List
Page 8 - Annex 3: Specifications
Subdocument 3 - EX-10.2 - EXHIBIT 10.2
Page 1 - Exhibit 10.2
Page 2 - COMPENSATION
Page 3 - Exhibit A
Page 4 - Change In Control
Page 5 - Separation from ServiceCodeSection 409A
Page 6 - Other Separation from Service
Page 7 - NOTICES
Page 8 - SEVERABILITY
Page 9 - NOVAN, INC.
Subdocument 4 - EX-10.3 - EXHIBIT 10.3
Page 1 - Exhibit 10.3
Page 2 - EXHIBIT A
Page 3 - Incorporation of Terms of Plan
Page 4 - Duration of Exercisability
Page 5 - Tax Withholding
Page 6 - Rights as Shareholder
Page 7 - Titles
Page 8 - Agreement Severable
Subdocument 5 - EX-10.4 - EXHIBIT 10.4
Page 1 - Exhibit 10.4
Page 2 - Cause
Page 3 - First Share Price Target First Target
Page 4 - Administration
Page 5 - Committee Decisions Final
Page 6 - Granting of Discretionary Bonus Amounts for the First Share Price Target.
Page 7 - Employment Requirement
Page 8 - Covered PaymentsParachute PaymentsExcise TaxReduced Amount"Net Benefit"
Page 9 - General Provisions
Page 10 - Governing Law
Page 11 - Expenses
Subdocument 6 - EX-31.1 - EXHIBIT 31.1
Page 1 - N/A
Subdocument 7 - EX-31.2 - EXHIBIT 31.2
Page 1 - N/A
Subdocument 8 - EX-32.1 - EXHIBIT 32.1
Page 1 - Exhibit 32.1
Page 2 - N/A
Subdocument 9 - EX-32.2 - EXHIBIT 32.2
Page 1 - Exhibit 32.2
Page 2 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (What's this?)
XBRL Viewer